Genetic Biocontrol Webinars

David O'Brochta and Hector Quemada,  GeneConvene Global Collaborative,  2021.

GeneConvene Global Collaborative

Webinar Series:

Genetic Biocontrol

Feb 3, 10, 17, 24 
11 am- 12:30pm
(Washington, D.C.)

In the mid 20th century various ideas emerged concerning how genetics and genetic principles could be directly applied to age-old problems of managing insects that threaten food security and public health.  This series of webinars will explore the current state-of-the-art of what has been termed genetic control, genetic pest management and genetic biocontrol.  It will cover the use of sterility, conditional dominant lethality and Wolbachia-induced cytoplasmic incompatibility.  Gene drive, another type of genetic biocontrol, will not be covered in this series; it was recently the focus of webinar series dedicated to the topic.  This webinar series is a scientific forum where one will hear and learn about the latest research in this area of applied genetics from those conducting the research.

Each seminar will be 45-50 minutes in length followed by questions and answers.

Not a convenient time?  Each webinar will be recorded and promptly posted on the GeneConvene Virtual Institute, and questions will be taken for 48 hours after the initial presentation. The speaker’s responses will be attached to the original presentation.

 

Feb 3, 2021

Self-Limiting Insects for Accessible and Sustainable Biological Pest Management

Speakers: Drs. Kevin Gorman and Nathan Rose, Oxitec, Ltd.

 

 

Feb 10, 2021

Using Wolbachia to control arboviruses

Speaker: Dr. Luciano Moreira, Fundação Oswaldo Cruz and World Mosquito Program

 

 

Feb 14, 2021             

Development of the SIT package against Aedes mosquitoes: progress and challenges

Speakers: Drs. Jeremy Bouyer and Kostas Bourtzis, Joint FAO/IAEA Programme Nuclear Techniques in Food and Agriculture

 

 

Feb 24 2021

Wolbachia bacteria as a ‘pesticide’ against mosquito populations

Speakers: Dr. Stephen Dobson, University of Kentucky and MosquitoMate, Inc.
Dr. Johanna Ohm, Verily Life Sciences